Literature DB >> 3408606

Pain as an indicator of bone metastasis.

E Palmer1, B Henrikson, K McKusick, H W Strauss, F Hochberg.   

Abstract

Patients with breast or prostate cancer routinely referred for bone scintigraphy were evaluated for the presence of skeletal pain, as determined by a self administered questionnaire. Pain was a common finding, whether or not metastatic disease was present, and occurred in over half of patients. Although most patients with bone metastases did report bone pain, a significant fraction (21% of breast and 22% of prostate patients) were asymptomatic. A distinct minority of individual anatomic regions of metastasis were painful: pain was reported in 23% of sites of breast metastases and 15% of metastatic prostate cancer sites. Of all sites at which pain was present, metastases were demonstrated in only about one half. These results indicate that pain is not a reliable indicator of the presence of location of metastatic bone disease.

Entities:  

Mesh:

Year:  1988        PMID: 3408606

Source DB:  PubMed          Journal:  Acta Radiol        ISSN: 0284-1851            Impact factor:   1.990


  4 in total

1.  Spinal pain due to metastasis of unknown origin.

Authors:  Susanna Stoll; Christian Taverna; Beat A Michel; Haiko Sprott
Journal:  Rheumatol Int       Date:  2005-02-02       Impact factor: 2.631

2.  Preventive or late administration of anti-NGF therapy attenuates tumor-induced nerve sprouting, neuroma formation, and cancer pain.

Authors:  Juan Miguel Jimenez-Andrade; Joseph R Ghilardi; Gabriela Castañeda-Corral; Michael A Kuskowski; Patrick W Mantyh
Journal:  Pain       Date:  2011-09-09       Impact factor: 6.961

Review 3.  Radioisotopic treatment of bone pain from metastatic prostate cancer.

Authors:  Oliver Sartor
Journal:  Curr Oncol Rep       Date:  2003-05       Impact factor: 5.075

4.  Disease trajectories and mortality among women diagnosed with breast cancer.

Authors:  Haomin Yang; Yudi Pawitan; Wei He; Louise Eriksson; Natalie Holowko; Per Hall; Kamila Czene
Journal:  Breast Cancer Res       Date:  2019-08-16       Impact factor: 6.466

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.